Implications of the success of EGFR-targeted therapy in advanced non-small cell lung cancer for its application to the adjuvant setting

被引：0
|
作者：
Takeda, Masayuki [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Med Oncol, 377-2 Ohno Higashi, Osaka 5898511, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2020年 / 12卷 / 08期
关键词：
1ST-LINE TREATMENT; OPEN-LABEL; CHEMOTHERAPY; ERLOTINIB; MULTICENTER;
D O I：
10.21037/jtd-2020-46
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：4553 / 4555
页数：3
相关论文
共 50 条
  • [1] Metabolic approach to EGFR-targeted therapy in non-small cell lung cancer
    Kam, Yoonseok
    Swain, Pamela
    Romero, Natalia
    Dranka, Brian P.
    CANCER RESEARCH, 2019, 79 (13)
  • [2] EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
    Antonicelli, Alberto
    Cafarotti, Stefano
    Indini, Alice
    Galli, Alessio
    Russo, Andrea
    Cesario, Alfredo
    Lococo, Filippo Maria
    Russo, Patrizia
    Mainini, Alberto Franco
    Bonifati, Luca Giuseppe
    Nosotti, Mario
    Santambrogio, Luigi
    Margaritora, Stefano
    Granone, Pierluigi Maria
    Dutly, Andre Emanuel
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03): : 320 - 330
  • [3] EGFR-TARGETED SELECTIVE GENE THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)
    Yamaguchi, Miki
    Nakamura, Kiminori
    Sakuragi, Naoya
    Kato, Kazunori
    Hamada, Hirofumi
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1056 - 1057
  • [4] Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond
    Delaney, Christopher
    Frank, Samuel
    Huang, R. Stephanie
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [5] NOVEL EGFR TARGETED THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 81 - 81
  • [6] Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
    Favorito, Valentina
    Ricciotti, Ilaria
    De Giglio, Andrea
    Fabbri, Laura
    Seminerio, Renata
    Di Federico, Alessandro
    Gariazzo, Eleonora
    Costabile, Silvia
    Metro, Giulio
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (02) : 139 - 154
  • [7] Current perspectives on the use of miRNA as a biomarker for EGFR-targeted therapy for non-small cell lung cancer
    Florczuk, Mateusz
    Szpechcinski, Adam
    Chorostowska-Wynimko, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 1207 - 1218
  • [8] Adjuvant therapy for locally advanced non-small cell lung cancer
    Keller, SM
    LUNG CANCER, 2003, 42 : S29 - S34
  • [9] Targeted therapies in advanced non-small cell lung cancer: Success or failure?
    Szutowicz E.
    Konopa K.
    Jassem J.
    memo - Magazine of European Medical Oncology, 2011, 4 (1) : 23 - 26
  • [10] Effect of EGFR-TKI targeted therapy in patients with advanced non-small cell lung cancer
    Yan, Meihao
    Chen, Shanshan
    Fan, Hongtao
    Hong, Yuancheng
    Huang, Wencheng
    Lin, Zhimin
    Lai, Zhangchao
    Hong, Liyue
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 7916 - 7923
12345